• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌男性患者雄激素剥夺治疗的并发症

Complications of androgen deprivation therapy in men with prostate cancer.

作者信息

Chen Allen C, Petrylak Daniel P

机构信息

Department of Medicine, College of Physicians and Surgeons, Columbia University, 177 Fort Washington Avenue, MHB 6-435, New York, NY 10032, USA.

出版信息

Curr Oncol Rep. 2004 May;6(3):209-15. doi: 10.1007/s11912-004-0051-0.

DOI:10.1007/s11912-004-0051-0
PMID:15066232
Abstract

Androgen deprivation therapy (ADT) is indicated for the treatment of metastatic prostate cancer and locally advanced disease. In addition to sexual side effects, long-term ADT results in several other changes, including hot flashes; gynecomastia; changes in body composition, metabolism, and the cardiovascular system; osteoporosis; anemia; psychiatric and cognitive problems; and fatigue and diminished quality of life. This review discusses these complications of ADT and treatments aimed at reducing them. It is important for clinicians to anticipate these effects and to initiate measures to prevent or minimize them in order to maintain quality of life in prostate cancer survivors.

摘要

雄激素剥夺疗法(ADT)适用于转移性前列腺癌和局部晚期疾病的治疗。除了性功能方面的副作用外,长期ADT还会导致其他一些变化,包括潮热;男性乳房发育;身体成分、代谢和心血管系统的改变;骨质疏松症;贫血;精神和认知问题;以及疲劳和生活质量下降。本综述讨论了ADT的这些并发症以及旨在减少这些并发症的治疗方法。临床医生必须预见到这些影响,并采取措施预防或尽量减少这些影响,以维持前列腺癌幸存者的生活质量。

相似文献

1
Complications of androgen deprivation therapy in men with prostate cancer.前列腺癌男性患者雄激素剥夺治疗的并发症
Curr Oncol Rep. 2004 May;6(3):209-15. doi: 10.1007/s11912-004-0051-0.
2
Complications of androgen-deprivation therapy in men with prostate cancer.前列腺癌男性雄激素剥夺治疗的并发症
Curr Urol Rep. 2005 May;6(3):210-6. doi: 10.1007/s11934-005-0009-2.
3
Preventing and treating the complications of hormone therapy.
Curr Urol Rep. 2005 May;6(3):217-23. doi: 10.1007/s11934-005-0010-9.
4
Adverse effects of androgen deprivation therapy and strategies to mitigate them.雄激素剥夺治疗的不良反应及其缓解策略。
Eur Urol. 2015 May;67(5):825-36. doi: 10.1016/j.eururo.2014.07.010. Epub 2014 Aug 2.
5
Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.雄激素剥夺治疗的副作用:监测与毒性最小化
Urology. 2003 Feb;61(2 Suppl 1):32-8. doi: 10.1016/s0090-4295(02)02397-x.
6
Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.雄激素剥夺疗法对前列腺癌男性患者及其伴侣的心理影响。
Cancer. 2015 Dec 15;121(24):4286-99. doi: 10.1002/cncr.29672. Epub 2015 Sep 15.
7
Androgen deprivation therapy: evidence-based management of side effects.雄激素剥夺疗法:副作用的循证管理。
BJU Int. 2013 Apr;111(4):543-8. doi: 10.1111/j.1464-410X.2012.11774.x. Epub 2013 Jan 25.
8
Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer.雄激素剥夺疗法和雌激素缺乏引起的不良反应在前列腺癌治疗中的作用。
Prostate Cancer Prostatic Dis. 2009;12(4):333-8. doi: 10.1038/pcan.2009.35. Epub 2009 Sep 1.
9
Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer.前列腺癌雄激素剥夺治疗期间的骨质疏松及其他不良身体成分变化
Cancer Metastasis Rev. 2002;21(2):159-66. doi: 10.1023/a:1020840311573.
10
Acupuncture for hot flashes in men treated with androgen deprivation therapy.针刺疗法治疗接受雄激素剥夺治疗的男性潮热症状。
Can J Urol. 2015 Aug;22(4):7938-41.

引用本文的文献

1
Current Clinical Aspects of Androgen Deprivation Therapy for Locally Advanced and Metastatic Prostate Cancer: A Scoping Review for Urologists and Medical Providers.局部晚期和转移性前列腺癌雄激素剥夺治疗的当前临床概况:泌尿外科医生和医疗服务提供者的范围综述
Res Rep Urol. 2024 Sep 16;16:187-193. doi: 10.2147/RRU.S467344. eCollection 2024.
2
Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis.第二代激素治疗的不良反应是否为疲劳?基于文献的荟萃分析数据。
Med Oncol. 2018 Jan 31;35(3):29. doi: 10.1007/s12032-018-1081-z.
3
Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder.

本文引用的文献

1
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.双膦酸盐的抗肿瘤作用:从基础研究到临床证据
Ann Oncol. 2003 Oct;14(10):1468-76. doi: 10.1093/annonc/mdg401.
2
Androgen deprivation and cognition in prostate cancer.前列腺癌中的雄激素剥夺与认知
Br J Cancer. 2003 Sep 15;89(6):971-6. doi: 10.1038/sj.bjc.6601235.
3
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.唑来膦酸预防非转移性前列腺癌雄激素剥夺治疗男性骨质流失的随机对照试验。
接受前列腺癌雄激素剥夺治疗的患者患抑郁症的风险增加。
PLoS One. 2017 Mar 2;12(3):e0173266. doi: 10.1371/journal.pone.0173266. eCollection 2017.
4
International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries.19个国家非转移性前列腺癌雄激素剥夺治疗(ADT)的国际调查。
ESMO Open. 2016 Mar 18;1(2):e000040. doi: 10.1136/esmoopen-2016-000040. eCollection 2016.
5
Potential role for metformin in urologic oncology.二甲双胍在泌尿肿瘤学中的潜在作用。
Investig Clin Urol. 2016 May;57(3):157-64. doi: 10.4111/icu.2016.57.3.157. Epub 2016 May 10.
6
Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer.前列腺癌手术联合或不联合放疗或单纯放疗后的并发症。
Br J Cancer. 2015 Mar 17;112(6):977-82. doi: 10.1038/bjc.2015.54.
7
Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.接受雄激素剥夺治疗的前列腺癌男性的抑郁症状学:一项对照比较。
Psychooncology. 2015 Apr;24(4):472-7. doi: 10.1002/pon.3608. Epub 2014 Jun 13.
8
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.肥胖与前列腺癌雄激素剥夺治疗后的体重增加几率
Prostate Cancer. 2014;2014:230812. doi: 10.1155/2014/230812. Epub 2014 Apr 22.
9
Severe gynecomastia due to anti androgens intake: A case report and literature review.抗雄激素摄入导致的严重男性乳房发育症:一例报告及文献综述
Indian J Endocrinol Metab. 2013 Jul;17(4):730-2. doi: 10.4103/2230-8210.113770.
10
Estrogenic side effects of androgen deprivation therapy.雄激素剥夺治疗的雌激素副作用。
Rev Urol. 2007 Fall;9(4):163-80.
J Urol. 2003 Jun;169(6):2008-12. doi: 10.1097/01.ju.0000063820.94994.95.
4
The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study.与去势相比,非甾体类抗雄激素药物比卡鲁胺(“康士得”)可能会维持骨密度:一项初步研究的结果。
World J Urol. 2003 May;21(1):37-42. doi: 10.1007/s00345-003-0322-7. Epub 2003 Mar 22.
5
Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.接受雄激素剥夺治疗的前列腺癌男性患者的抗阻运动。
J Clin Oncol. 2003 May 1;21(9):1653-9. doi: 10.1200/JCO.2003.09.534.
6
Fracture risk following bilateral orchiectomy.双侧睾丸切除术后的骨折风险。
J Urol. 2003 May;169(5):1747-50. doi: 10.1097/01.ju.0000059281.67667.97.
7
Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma.前列腺癌男性患者治疗相关骨质疏松症的诊断与管理
Cancer. 2003 Feb 1;97(3 Suppl):789-95. doi: 10.1002/cncr.11149.
8
Intermittent androgen suppression for prostate cancer: rationale and clinical experience.前列腺癌的间歇性雄激素抑制:理论依据与临床经验。
Prostate Cancer Prostatic Dis. 1998 Dec;1(6):289-296. doi: 10.1038/sj.pcan.4500260.
9
Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study.接受雄激素剥夺治疗的前列腺癌男性患者的抑郁情况:一项试点研究。
Psychooncology. 2002 Nov-Dec;11(6):518-23. doi: 10.1002/pon.592.
10
Effects of exercise on physiological and psychological variables in cancer survivors.运动对癌症幸存者生理和心理变量的影响。
Med Sci Sports Exerc. 2002 Dec;34(12):1863-7. doi: 10.1097/00005768-200212000-00001.